Can better Doctor-Patient bonds reduce cancer care disparities?
NCT ID NCT04342611
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how trust and communication (called a therapeutic alliance) between Latino/a advanced cancer patients and their oncologists might affect care. Researchers interviewed 4 doctors and held focus groups with 10 patients to understand barriers and what helps build a strong relationship. The goal was to learn how to reduce disparities in end-of-life cancer care for Latino communities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
23 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will include patients and oncologists. The study population of patients will be drawn from patients who receive the majority of their oncologic care at the Duarte campus of City of Hope who meet the eligibility criteria as described above. There will be 10 patients recruited to participate in focus groups. Oncologists who work at City of Hope and serve the above defined patient population at the Duarte campus of City of Hope will be identified by convenience and purposive sampling. In-depth interviews will be conducted with 4 oncologists.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: 1. identifying as ethnically Latino/a; 2. locally advanced or metastatic cancer (gynecologic, lung, gastrointestinal, colorectal) and have experienced disease progression on at least first-line chemotherapy and 3. ability to provide informed consent. Patient exclusion criteria include: 1. not fluent in English or Spanish; 2. severely cognitively impaired \[44\]; 3. too ill or weak to participate in a focus group ; 4. age under 21; and 5. patients deemed inappropriate for the study by their treating oncologist.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a gentler blood thinner shield cancer patients from new clots?
- Can more phone calls after cancer surgery keep patients out of the hospital?
- Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
- Matching cancer survivors to the right level of support
- Can colorectal surgery patients go home in two days?